Skip to content

Modified Fome-Cuf Silicone Tracheostomy Tube

by Bivona Medical Technologies 2 variants

510(k) K885129

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK885129 Date27 Feb 1989ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
JOH
Device Class
Class II
Regulation
21 CFR Part 868.5800
Advisory Committee
Anesthesiology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Modified Fome-Cuf Silicone Tracheostomy Tube is a tracheostomy tube designed for airway management in patients requiring long-term mechanical ventilation or tracheostomy. It features a silicone construction with an auto-expanding foam cuff that conforms to the tracheal wall, providing a secure seal while minimizing pressure on surrounding tissues. This design reduces the risk of tracheal injury and enhances patient comfort during prolonged use.

This device is intended for single-use in clinical settings such as intensive care units (ICUs) and operating rooms. Supplied sterile, it is classified as a Class II medical device under FDA regulations (510(k) clearance, K885129). The tube is available in multiple sizes and configurations, as indicated by the associated FEI numbers, and must be stored according to manufacturer guidelines to maintain sterility and integrity. No MRI safety information is specified in the regulatory data.

Other devices from Bivona Medical Technologies

See all devices from Bivona Medical Technologies →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Modified Fome-Cuf Silicone Tracheostomy Tube used for?

    This device is designed for airway management in patients requiring long-term mechanical ventilation or tracheostomy. Its silicone construction and auto-expanding foam cuff conform to the tracheal wall, providing a secure seal while minimizing pressure on surrounding tissues. This reduces the risk of tracheal injury and enhances patient comfort during prolonged use.

  • Is the Modified Fome-Cuf Silicone Tracheostomy Tube single-use or reusable?

    The Modified Fome-Cuf Silicone Tracheostomy Tube is intended for single-use in clinical settings like ICUs and operating rooms. This ensures sterility and reduces the risk of cross-contamination between patients.

  • How is it supplied, and what does sterility mean for this device?

    The device is supplied sterile to ensure safe clinical use. Sterility means it has been processed to eliminate or reduce viable microorganisms to a level that meets regulatory standards, preventing infection risk in patients.

  • What sizes and configurations are available for this tracheostomy tube?

    The Modified Fome-Cuf Silicone Tracheostomy Tube comes in multiple sizes and configurations, each identified by a unique FEI number (e.g., 3009771213, 3021632375). These variations accommodate different patient anatomies and clinical needs, ensuring proper fit and function.

  • How should this device be stored to maintain its integrity?

    To preserve sterility and functionality, the device must be stored according to the manufacturer’s guidelines. This typically includes keeping it in its original packaging, away from direct sunlight, extreme temperatures, and moisture, until immediate clinical use.